Transplantation between genetically disparate individuals requires chemotherapeutic agents to suppress the rejection reaction. Although these agents are vital to the suppression of graft rejection, they have their own deleterious side effects caused by both nonspecific immunosuppression and drug toxicities. In addition, chronic rejection in varying degrees of severity often occurs despite the use of these agents.
plaster cast to prevent shearing. If more than one skin graft was placed on an animal, each defect for graft placement was separated by a 3-ram or larger skin bridge. Casts were removed on the eighth day. Grafts were scored daily for percent rejection, and rejection was considered complete when no residual viable graft could be seen. Graft survivals were calculated by the life-table method and the median survival time (MST) was derived from the time point at which 50% of grafts were surviving.
Splenectomy. Partial splenectomy was performed under ether general anesthesia through a left subcostal oblique incision. The vessels supplying the segment of spleen to be harvested were crushed with a mosquito snap as they emanated from the splenic hilum and the distal segment of spleen was amputated with iris scissors. A two-layer closure with 3-0 silk was performed.
Mixed Lymphocyte Reactions. Mixed lymphocyte reactions (MLR) were performed as previously described (12) . Briefly, routine and rat splenocytes were ACK-lysed (ammonium chloride potassium carbonate lysing buffer) (NIH Media Unit), washed, and reconstituted in EHAA (12) (NIH Media Unit) supplemented with 0.75% normal mouse serum, 0.09 mM nonessential amino acids, 1 mM sodium pyruvate, 2 mM glutamine, 100 U/ml penicillin, 100 #g/ml streptomycin, and 0.05 mM 2-mercaptoethanol. Either 2 X 105 or 4 x 105 responders were stimulated with 4 × 105 stimulators (2,000 rad) and varying numbers of co-cultured putative suppressors or control normal cells in a total of 200 or 250 ul of media. Cultures were incubated at 37 °C in 5% CO~ for 4 d, pulsed on the third day with 1 uCi [SH]thymidine (New England Nuclear, Boston, MA), and harvested on the fourth day with an automated harvester (Mash II; Microbiological Associates, Bethesda, MD).
Cell-mediated Lympholysis (CML).
Xenogeneic CML assays were performed using a modification of techniques described elsewhere (12) (13) (14) . Briefly, RPMI 1640 medium (Gibco Laboratories) was supplemented as above, except that 10% fetal calf serum (Gibco Laboratories) was used in place of normal mouse serum. Additionally, rat lymph node target cells were cultured in media with 10% normal rat serum in lieu of fetal calf serum. 4 x 106 responders were co-cultured with 2 x 106 or 4 x 106 putative suppressors or control cells and 4 x 105 splenocyte stimulators (2,000 rad) in 2.5 ml of medium at 37°C for 5 d. Mouse target blasts were stimulated with concanavalin A (Con A) (Miles Yeda Research Products, Rehovot, Israel) for 2-3 d. Rat lymph node target cells were stimulated with phytohemagglutinin (PHA) (Gibco Laboratories) at a dilution of 1:400 for 3-4 d. After 5 d responders were harvested, counted, and resuspended at appropriate effectorto-target ratios with 1 x 104 5~Cr-labeled, 2-3-d Con A mouse splenocyte blasts or 3-4-d PHA rat lymph node blasts as targets. After 4.5 h, supernatants were harvested with the Titertek supernatant harvesting system and specific lysis was calculated as follows: specific lysis = (experimental release -spontaneous release)/(maximal HCI release -machine background) x 100. Spontaneous release was <25% of maximum release unless otherwise indicated.
IgG1 and lgG2 Isotype Levels. Levels of IgG1 and IgG2 against donor lymphoid elements in sera were assessed by a direct binding assay on the FACS using purified FITCGAMIgG1 and IgG2 reagents (provided by Dr. Howard Dickler, National Institutes of Health) as previously described (9) .
Plaque-forming Cell (PFC) Assays. Sheep red blood cell (SRBC) PFC assays were performed as previously described (15) . Briefly, animals were immunized intravenously with 0.2 cc of a 1% SRBC suspension on day 0. Partial splenectomies were performed on day 5, splenic lymphoid cells were harvested as resuspended in Hanks' balanced salt solution with phenol red (M.A. Bioproducts, Walkersville, MD), and the standard plaqueforming assay was performed in triplicate at 1:10, 1:100, and 1:1,000 spleen cell equivalents to ensure the optimal number of plaques per slide. Values are reported as plaques per 106 spleen cells. All experiments reported were read blind.
Results

Survival of Mice Reconstituted with Fully Xenogeneic or Mixed Xenogeneic Bone
Marrow Inocula. Because we were interested in reconstituting mice with xeno- geneic bone marrow in an attempt to induce specific tolerance to subsequent xenografts, we first attempted fully xenogeneic marrow transplantation (F344 rat ~ B 10). However, this approach was unsuccessful because survival of fully xenogeneically reconstituted animals was extremely poor, leading ultimately to death in all but one animal (Fig. 1) . In contrast, B 10 recipient mice reconstituted with a mixture of syngeneic and xenogeneic F344 rat bone marrow cells showed a long-term survival similar to B10 animals reconstituted with syngeneic bone marrow. Survival was 100% at 00 d and 86% at 100 d (Fig. 1) . The mixed reconstituted animals all appeared healthy, showing none of the wasting and debilitation exhibited in control animals reconstituted simultaneously with identically treated rat bone marrow cells alone. All unreconstituted control animals died within 2 wk of irradiation.
Titration of Syngeneic and Xenogeneic Bone Marrow Cells Required for Reconstitution.
Titrations were performed to determine the optimal number of syngeneic and xenogeneic T cell-depleted bone marrow cells required to achieve reproducible reconstitution and tolerance. Although 1 x 106 syngeneic bone marrow cells was sufficient for survival in 80% of animals, a dose of 5 x 106 cells was chosen since at this dose reconstitution was observed in 100% of animals (data not shown).
Optimal numbers of xenogeneic bone marrow cells required for induction of hyporeactivity was determined by skin xenograft survival in mixed xenogeneically reconstituted animals (Fig. 2) . Mixed reconstitution of animals with 1.0 x 107 T Cell-depleted F344 rat bone marrow cells or less led to prompt rejection of skin xenografts in 100% of animals, while animals reconstituted with greater than this number of cells exhibited prolongation of skin xenografts to varying degrees. In all animals, the grafts eventually underwent a chronic form of rejection with ultimate disappearance of the grafts in most animals. Although mixed reconstitution with 2.0 x 107 T cell-depleted F344 bone marrow cells led to specific skin xenograft prolongation in the majority of the animals, the onset of chronic rejection occurred more rapidly and was more severe than in 
Typing of Mixed Xenogeneically Reconstituted Mice.
Typing of the mixed xenogeneically reconstituted animals by trypan blue exclusion microcytotoxicity assay revealed low numbers, if any, of detectable rat lymphoid elements in peripheral blood. Because the sensitivity of this assay is inadequate for accurate determination of such low percentages of lymphoid cells, further analysis of the animals was pursued by flow microfluorometry (FMF) using splenic lymphoid cells and MLR typing in which chimeric cells were used as stimulators of normal B10 responding cells. Analyses performed by FMF (FACS II) revealed that 0.5% of F344 rat cells could be detected when mixed with B10 splenocytes and stained with mouse anti-rat sera. There was no cross-reactivity of the anti-H-2 b monoclonal and mouse anti-rat sera used in staining on the inappropriate species. A fully xenogeneic chimera examined at 30 d post-reconstitution revealed 75% rat cells and 40% H-2b-bearing cells present in splenic tissue (Fig. 3) , which indicates that rat antigen could be detected in chimeric animals. Under these staining conditions, rat cells were detectable at very low levels in only 20% (5/25) of mixed xenogeneically reconstituted animals tested from 6 to 16 wk post-reconstitution. Fig.  3 illustrates one representative animal with a low level of rat cells detectable. Rat cells were not detectable in thymus, bone marrow, peripheral blood, and lymph node examined in similar fashion (data not shown) despite the persistence of an F344 skin graft for >50 d. stimulate a proliferative response in normal B10 responding cells. However, some animals, such as chimera 1, did produce a response, which indicates the possible persistence of xenogeneic elements.
Specific Hyporeactivity to Donor-Type Skin Grafts. Mixed xenogeneically recon-
stituted animals demonstrated reproducible specific hyporeactivity to donor-type full-thickness tail skin grafts (MST = 80 d) (Fig: 4) . However, rejection of thirdparty aliografts (Fig. 4) and xenografts (Table II) followed a time course similar to that of syngeneically reconstituted animals ( Fig. 4) and nonirradiated controls. The skin grafts varied in appearance and texture from soft to indurated, often with an appearance of prolonged chronic rejection. In the majority, the onset of the appearance of chronic rejection was from 20 to 90 d. However, in some animals, the grafts remained soft and uninflammed for up to 120 d. To evaluate the degree of specificity of hyporeactivity to rat skin grafts, mice reconstituted with T cell-depleted syngeneic (B10) plus either T cell-depleted F344 or WF bone marrow were grafted with both F344 and WF tail skin simultaneously. All skin grafts were read blind for the first 33 d. Grafts were considered rejected when no viable residual could be detected. As shown in Table II , it was clear that hyporeactivity to donor-type skin was specific, since with few exceptions mice reconstituted with F344 bone marrow retained F344 skin grafts but specifically rejected WF skin grafts with a time course similar to syngeneically (B 10 ~ B 10) reconstituted animals. Conversely, mice reconstituted with B 10 plus WF bone marrow were hyporeactive to WF skin but rejected F344 rat tail skin grafts with a time course similar to syngeneically reconstituted animals.
Serologic Reactivity and Attempts to Detect Enhancement. Sera obtained sequentially following skin grafting of mixed xenogeneically reconstituted animals were tested on F344 rat spleen target cells by complement-mediated cytotoxicity. Table III shows the cytotoxic titers and maximum percentage lysis of F344 target cells by sera from five representative animals. Included are data from one The majority of mixed, xenogeneically reconstituted mice specifically rejected third-party rat. The two exceptions to this in which third-party rat was prolonged were probably due to a degree of immunoincompetence in these animals. animal, chimera A, which rejected its F344 graft with a more rapid time course than most of the other animals. That animal demonstrated a relatively high titer and maximum percent kill, while the other animals exhibited a lower level of lysis similar to that for normal serum, while their skin grafts remained intact. Because serologic enhancement could be one possible mechanism responsible for the prolonged acceptance of the F344 skin grafts, we examined the sera of experimental animals with grafts still intact for enhancing antibody. Because IgG1 and IgG2 have been demonstrated to be most commonly involved in enhancement (16), we directed our attention to analysis of levels of these two isotypes. Analysis of the sera from bleeds taken after reconstitution but before skin grafting and from day 50 after skin grafting revealed no increase in levels of gamma 1 or gamma 2 antibodies directed at F344 lymphoid cells by direct binding assay on the FACS using purified FITC-GAMIgG1 and IgG2 reagents. In fact, suppression of IgG1 and IgG2 levels was noted in some animals following skin grafting (Table IV) .
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In addition, an attempt was made to passively transfer such hyporeactivity to normal B 10 animals. Serum from animals with rat skin grafts intact from 30 to 90 d was transferred (0.5 cc intravenously per normal B 10) 4 h before placement of F344 rat and B10.D2 skin grafts. Control animals were unmanipulated. The rat and allogeneic skin grafts were rejected with identical time courses in the control and experimental animals (data not shown).
Specific Tolerance to Donor-Type Lymphoid Elements as Evidenced by MLR.
As seen in a representative mixed lymphocyte culture (Table V) , no response of chimeras to either host or donor-type stimulator cells was observed. Although the mixed xenogeneically reconstituted animals were somewhat suppressed in their overall responses, their responses to third party stimulators were present and specific. If one compares the ratios of response of the experimental animals to WF or B10.BR with that to F344, it can be seen that the ratios are much greater than that of normal B 10 to the same stimulators, which indicates specific tolerance to donor-type antigens. The response of normal control B 10 lymphocytes against F344 rat splenocytes in co-culture with chimeric cells has revealed no evidence for suppression (Table  VI) . Furthermore, titration of increasing numbers of co-cultured chimeric cells up to 1.6 x 106 cells with 4 x 10 ~ normal B10 responding cells again failed to reveal evidence for suppression of the B10 anti-F344 response (data not shown). In addition, no suppression was seen in the reverse direction when F344 rat lymphocyte responding cells were co-cultured with unirradiated chimeric splenocytes and C57BL/10Sn stimulators (data not shown).
Specific Tolerance to Donor-Type Lymphoid Elements as Evidenced by CML.
Cells from mixed xenogeneically reconstituted animals were examined in an in vitro CML sensitization. In one-way CML, responding cells were cultured with F344, B10, or third party murine or rat stimulators. Such attempts to sensitize (B10 + F344 ~ B10) spleen cells did not lead to cytotoxicity for either host (B10) or donor (F344)-type Con A-or PHA-stimulated blasts, but did lead to effective lysis of third-party mouse (B 10.BR) and rat (WF) target cells (Fig. 5) . This specific hyporeactivity persisted even after the onset of chronic rejection and eventual rejection of F344 skin grafts. Syngeneically reconstituted animals tested simultaneously demonstrated an anti-F344 and anti-third-party response at levels similar to normal B10 control responding cells. To detect suppression, normal B 10 responder cells were co-cultured with unirradiated spleen cells from mixed xenogeneically resconstituted animals and F344 stimulators or third-party stimulators. In these experiments, co-culture of chimeric cells with normal B10 responder cells did not diminish the anti-F344 response or the anti-third-party response, and thus provided no evidence for specific or nonspecific suppression (Fig. 6) .
Immunocompetence as Assessed by PFC Responses. In an attempt to further assess the in vivo immunocompetence of the mixed xenogeneically reconstituted animals, animals were subjected to intravenous immunization with SRBC suspensions and their ability to form PFC responses was quantitated. The responses of the mixed xenogeneically reconstituted mice were found to be immunocompetent and similar to syngeneically (B10 --~ B10) reconstituted mice in B cell and helper T cell interactions as assessed by their PFC responses. Fully xenogeneically reconstituted animals did not survive long enough for evaluation, and fully ailogeneic chimeras were therefore chosen as the most appropriate available controls. As seen in Table VII , the majority of fully allogeneic chimeras (B 10.D2 B 10) responded less well than did mixed xenogeneically reconstituted animals. Discussion Animal models for fully xenogeneic chimeras have been less extensively investigated than those for allogeneic chimeras. This is in part due to the poor survival of such animals, presumably secondary to graft vs. host disease (17) and probable immunoincompetence due to a failure of appropriate immune cell interactions in the reconstituted host similar to that described in fully allogeneic chimeras (18, 19) . In our experience, the absence of wasting disease and excellent survivals in the mixed xenogeneically reconstituted animals was in striking contrast to those animals reconstituted with identically treated T cell-depleted F344 bone marrow cells alone. It is difficult to assess whether the death of the fully xenogeneically reconstituted animals was due to graft vs. host disease or immunoincompetence. One can only conclude that their survival is poor but prolonged over that of radiation controls if the animals are reconstituted with >2.0 X 10 7 Y cell-depleted F344 rat bone marrow cells.
It is apparent from our data that the persistence of a high level of donor-type lymphoid cells is not a requirement for prolonged in vivo and in vitro hyporeactivity to donor-type elements. In this aspect, the mixed xenogeneic model resembles neonatal tolerance as first described by Billingham et al. (1) , in which only very small numbers of donor-type cells have been found (20) . In fact, the percentage of rat cells detectable in peripheral lymphoid tissue was not a reliable prognosticator for the duration of skin xenograft prolongation or for the severity and temporal relationship of the chronic rejection reaction that eventually appeared in the skin grafts. The hyporeactivity to F344 rat antigens was manifested in varying degrees, depending upon the assay used. Although all mixed xenogeneically reconstituted animals manifested specific prolongation of skin xenograft survival, most grafts eventually underwent a chronic rejection and were slowly rejected. In contrast, in vitro specific hyporeactivity to F344 lymphocytes as assessed by MLR and CML was permanent and persisted even after the loss of F344 skin grafts following the prolonged chronic rejection.
Enhancement by serum factors has been proposed as one mechanism contributing to tolerance (16, 21) . Voisin (21) reported no significant change in levels of IgG1 and IgA from pre-skin grafting to post-skin grafting in a neonatal murine chimera system, although both of these levels were elevated in comparison with normal control animals. In our system, the levels of IgG1 and IgG2 anti-rat antibody detectable in mixed xenogeneically reconstituted animals decreased or remained unchanged in animals retaining their rat tail skin grafts. However, before skin grafting, all animals had a degree of cytotoxic antibody directed against F344 splenic target cells after bone marrow grafting. In all animals that retained their xenografts for a prolonged period, the cytotoxic titer and maximum percentage lysis of donor-type target cells decreased or remained unchanged. In contrast, the titer and maximum lysis by serum from the one animal that rejected its skin graft rapidly remained elevated. These data could be suggestive of a possible humoral factor contributing to the specific hyporeactivity observed in vivo and in vitro in mixed xenogeneicaily reconstituted animals, although attempts to demonstrate enhancement with serum from hyporeactive animals were unsuccessful. Serum antibody could also represent a lack of tolerance at the humoral level to donor-type xenogeneic lymphoid elements. In either case, specific hyporeactivity to skin xenografts and to donor-type lymphoid antigens in vitro appear in this model to occur in the presence of specific antibody production to F344 lymphoid cells.
In search of putative active suppression, we performed mixing experiments in which chimeric lymphocytes were co-cultured with normal B10 or normal F344 responding cells and B10, F344, or third-party stimulators in mixed lymphocyte culture. We chose mixed reconstituted animals with skin grafts still intact with the presumption that the strong antigenic stimulus of an intact skin graft might expand a possible suppressor cell population. However, neither specific nor nonspecific suppression of the proliferative reaction in MLR and cytotoxic lymphocyte reaction in CML could be demonstrated in numerous experiments.
In addition, no suppression of the F344 rat anti-B10 MLR response was noted in co-culture experiments.
Although small percentages of donor-type cells have been identified in various lymphoid compartments of some of the mixed xenogeneically reconstituted animals, many animals have had no donor-type cells detectable. However, all animals have demonstrated prolongation of donor-type skin graft survival beyond that of syngeneically reconstituted controls. Because skin is strongly antigeneic and the survival of skin grafts is frequently more difficult to prolong than most other solid organs (22) , it seems likely that animals manifesting this level of hyporeactivity would be highly tolerant to xenografts of kidney, heart, or other vascularized organs. Studies are currently in progress involving heterotopic caridac xenograft transplantation in such animals to assess this possibility.
This new approach may provide a model for investigation of mechanisms of self-recognition and antigen processing in addition to that of transplantation tolerance. While clinical applications of mixed xenogeneic bone marrow reconstitution would be premature, the approach may offer advantages for bone marrow and cadaver donor organ transplantation. Single high-dose radiation and immediate mixed reconstitution coincident with solid organ transplantation could, for example, afford immediate use of donor organs with potential for prolonged acceptance of the donor allograft or xenograft in the absence of prolonged nonspecific chemical immunosuppressive agents. Attempts to extend these studies to a large animal model are in progress.
Summary
Mixed xenogeneically reconstituted mice (F344 rat + C57BL/10Sn ~ C57BL/ 10Sn), which specifically retain F344 tail skin xenografts, were studied for the specificity of such hyporeactivity and for in vitro reactivity and immunocompetence. Survival of mixed reconstituted animals was excellent, without evidence for graft vs. host disease. Donor-type tail skin grafts were specifically prolonged (mean survival time = 80 d) in comparison with normal controls and syngeneically reconstituted animals. In vitro, such animals manifested specific hyporeactivity by mixed lymphocyte reaction and cell-mediated lympholysis to F344 rat and B10 cells, with normal response to third-party rat (Wistar-Furth) and mouse (B10.BR). Examination of lymphoid tissues with a fluorescence-activated cell sorter revealed low levels, if any, of donor-type cells detectable. This system offers a model for investigation of xenogeneic transplantation tolerance.
